BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/25/17 Galenica (GALN.VX) Retacrit for Anemia Due to Chronic Renal Failure, Dialysis-Dependent Subscribers Only Subscribers Only Subscribers Only
5/25/17 MYR GmbH Myrcludex B for Hepatitis D (HDV) (Antiviral) Subscribers Only Subscribers Only Subscribers Only
5/24/17 Aerie Pharmaceuticals (AERI) Roclatan for Glaucoma / Ocular Hypertension (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
5/24/17 Eli Lilly (LLY) Taltz for Psoriatic Arthritis (PA) Subscribers Only Subscribers Only Subscribers Only
5/24/17 Bristol-Myers Squibb (BMY) Opdivo for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
Now - 05/26/17 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
05/26/17 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
05/26/17 Subscribers Only Subscribers Only Patent - Expiration
05/26/17 Subscribers Only Subscribers Only Trial Data - Other
Now - 05/27/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results